Prognostic Impact of Immunoglobulin Kappa C (<i>IGKC</i>) in Early Breast Cancer.
Marcus Schmidt, Karolina Edlund, Jan G. Hengstler, Anne-Sophie Heimes, Katrin Almstedt, Antje Lebrecht, Slavomir Krajnak, Marco Johannes Battista, Walburgis Brenner, Annette Hasenburg, Jörg Rahnenführer, Mathias Gehrmann, Pirkko‐Liisa Kellokumpu‐Lehtinen, Ralph M. Wirtz, Heikki Joensuu
Abstract
= 0.855 and 0.684, respectively). These results show that humoral immunity beneficially influences the DDFS of patients with early TNBC.
Topics & Concepts
TrastuzumabMedicineInternal medicineOncologyBreast cancerDocetaxelProportional hazards modelVinorelbineAdjuvantTriple-negative breast cancerPopulationAntibodyChemotherapyCancerImmunologyCisplatinEnvironmental healthHER2/EGFR in Cancer ResearchCancer Immunotherapy and BiomarkersCancer Cells and Metastasis